The scale of Nvidia's European bet, by the numbers

Nvidia had already poured roughly $8 billion into Europe over the prior year[1], and in Paris Huang previewed a fresh $2 billion tranche of European AI deals due the following week[1]. Days later in London, $1.16 billion of that new money landed on five UK startups - Boltz, Foresight, Hiverge, Prima Mente and Riverlane[2]- spanning drug discovery, infrastructure forecasting, algorithm design, epigenetics and quantum error correction[3]. Four more French startups (Doctolib, Entalpic, Genesis AI, Pigment) picked up additional stakes, bringing the named UK-and-France roster to nine companies with roughly $1.227 billion in prior combined funding[3]. Layered on top is a separate $250 million, five-year compute commitment earmarked purely for AI safety research at Oxford, UCL and Imperial College London[4]- a sum that is small next to the investment totals but notable because it is not equity, it is a research subsidy. Seen together, the UK's single-week haul of new money is already close to a seventh of everything Nvidia spent across the entire continent the year before.


